These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15715354)

  • 41. [Agranulocytosis and septic shock after metamizole use].
    Oude Munnik TH; Annink-Smoors M; Hom HW; Sportel ET
    Ned Tijdschr Geneeskd; 2016; 160():A9464. PubMed ID: 26840935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonchemotherapy drug-induced agranulocytosis in elderly patients: the effects of granulocyte colony-stimulating factor.
    Andrès E; Kurtz JE; Martin-Hunyadi C; Kaltenbach G; Alt M; Weber JC; Sibilia J; Schlienger JL; Dufour P; Maloisel Fr
    Am J Med; 2002 Apr; 112(6):460-4. PubMed ID: 11959056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of drug-induced agranulocytosis with colony stimulating factors (G-CSF or GM-CSF).
    Góra-Tybor J; Krykowski E; Robak T
    Arch Immunol Ther Exp (Warsz); 1996; 44(4):255-8. PubMed ID: 9017166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Adequacy of the safety of metamizole and agranulocytosis].
    Garcia Del Campo C; Murcia Soler M; Martinez-Mir I; Palop Larrea V
    Aten Primaria; 2021; 53(6):102047. PubMed ID: 33823317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis.
    Andrès E; Maloisel F; Zimmer J
    Br J Haematol; 2010 Jul; 150(1):3-8. PubMed ID: 20151980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Life-threatening agranulocytosis, anemia, and plasmacytosis after dipyrone use for fever in a child.
    Işık M; Kaya Z; Belen FB; Aktaş AT; Tezer H; Gürsel T
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):e46-8. PubMed ID: 23007418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Fatal Outcome of Agranulocytosis after Re-Exposure to Metamizole and Cefepime-Induced Encephalopathy].
    Skaistys A; Rätz Bravo AE; Leuppi-Taegtmeyer A; Zysset Y
    Praxis (Bern 1994); 2019 Aug; 108(10):693-697. PubMed ID: 31387493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dipyrone (metamizole) use in the United States: a lethal tango?
    Moorman J
    South Med J; 2006 Sep; 99(9):916. PubMed ID: 17004522
    [No Abstract]   [Full Text] [Related]  

  • 49. Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients.
    Rudin D; Spoendlin J; Cismaru AL; Liakoni E; Bonadies N; Amstutz U; Meier CR; Krähenbühl S; Haschke M
    Eur J Intern Med; 2019 Oct; 68():36-43. PubMed ID: 31383393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sulfasalazine-induced DRESS and severe agranulocytosis successfully treated by granulocyte colony-stimulating factor.
    Fathallah N; Slim R; Rached S; Hachfi W; Letaief A; Ben Salem C
    Int J Clin Pharm; 2015 Aug; 37(4):563-5. PubMed ID: 25854308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Recall of metamizole from the market in countries with modern pharmacotherapy].
    Mihajlović G
    Srp Arh Celok Lek; 1996; 124(1-2):44-6. PubMed ID: 9102814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The efficacy and rapidity of action of granulocyte colony-stimulating factor in a case of agranulocytosis due to noramidopyrine].
    Neri A; Cibin M; Fernandes D; Gibin P; Lio S; Marcello R; Scarpa A; Ruffin M
    Recenti Prog Med; 1994 May; 85(5):284. PubMed ID: 7517568
    [No Abstract]   [Full Text] [Related]  

  • 53. [Methamizole-induced agranulocytosis].
    Pedrazas López D; de Pablo Márquez B; García Font D; Sánchez García E
    Med Clin (Barc); 2016 Apr; 146(7):e41. PubMed ID: 26602309
    [No Abstract]   [Full Text] [Related]  

  • 54. [17-year-old patient with neutropenia and fever during therapy with analgesics].
    Pfersdorff M; Spes J; Kraus MR
    Dtsch Med Wochenschr; 2011 Feb; 136(8):365-8. PubMed ID: 21332035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Idiosyncratic drug-induced agranulocytosis or acute neutropenia.
    Andrès E; Maloisel F
    Curr Opin Hematol; 2008 Jan; 15(1):15-21. PubMed ID: 18043241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The use of metamizole as a risk factor in the occurrence of agranulocytosis].
    Vlakhov V; Bakracheva N; Popova L
    Vutr Boles; 1988; 27(2):80-5. PubMed ID: 3046147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Rare Case of Intravenous Metamizole Abuse.
    Nazlı ŞB; Sevindik M
    Turk Psikiyatri Derg; 2021; 32(1):70-71. PubMed ID: 34181748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advise against metamizole.
    Neumann J
    Dtsch Arztebl Int; 2009 Jan; 106(4):55-6; author reply 56. PubMed ID: 19564968
    [No Abstract]   [Full Text] [Related]  

  • 59. [Drug-induced agranulocytosis: clinical study of 19 cases].
    Márquez JA; Pardo C; Amutio E; Cortés C; Piñán MA; Alvarez C
    Sangre (Barc); 1998 Oct; 43(5):436-8. PubMed ID: 9868339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hematopoietic growth factors as supportive treatment in drug-induced agranulocytosis].
    Hospers GA; de Wolf JT; Hazenberg BP; Vellenga E
    Ned Tijdschr Geneeskd; 1993 Oct; 137(42):2152-4. PubMed ID: 7694163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.